Researcher profile · Semantic Scholar

M. Kaufman

h-index: 16
Works: 41
Citations: 1,798

Most-cited papers

Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta.
D. Wynn, M. Kaufman, X. Montalban, T. Vollmer +8 more
2010Lancet Neurology318 citations
Semantic Scholar
Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
L. Kappos, H. Wiendl, K. Selmaj, D. Arnold +9 more
2015New England Journal of Medicine254 citations Open access
Semantic Scholar
The significant change for the Timed 25-Foot Walk in the Multiple Sclerosis Functional Composite
M. Kaufman, D. Moyer, J. Norton
2000Multiple Sclerosis231 citations
Semantic Scholar
MS disease activity in RESTORE
Robert J. Fox, B. Cree, J. de Sèze, Ralf Gold +10 more
2014Neurology189 citations Open access
Semantic Scholar
Relationships between information processing, depression, fatigue and cognition in multiple sclerosis.
B. Diamond, Susan K. Johnson, M. Kaufman, L. Graves
2008Archives of Clinical Neuropsychology177 citations
Semantic Scholar
MRI predictors of early conversion to clinically definite MS in the CHAMPS placebo group
J. Simon, P. O'Connor, P. Fleming, T. Gray +95 more
2002Neurology94 citations
Semantic Scholar
Natalizumab treatment shows no clinically meaningful effects on immunization responses in patients with relapsing-remitting multiple sclerosis.
M. Kaufman, G. Pardo, H. Rossman, M. Sweetser +2 more
2014Journal of Neurological Sciences78 citations
Semantic Scholar
Multiple Sclerosis: Severity and Progression Rate in African Americans Compared with Whites
M. Kaufman, Susan K. Johnson, D. Moyer, Jessica Bivens +1 more
2003American Journal of Physical Medicine & Rehabilitation74 citations
Semantic Scholar
The effect of Ginkgo biloba on functional measures in multiple sclerosis: a pilot randomized controlled trial.
Susan K. Johnson, B. Diamond, S. Rausch, M. Kaufman +2 more
2006Explore67 citations
Semantic Scholar
Is Chlamydia pneumoniae found in spinal fluid samples from multiple sclerosis patients? Conflicting results
M. Kaufman, Charlotte A. Gaydos, S. Sriram, J. Boman +2 more
2002Multiple Sclerosis44 citations
Semantic Scholar
Course of relapsing–remitting multiple sclerosis before, during and after natalizumab
M. Kaufman, R. Lee, H. Norton
2011Multiple Sclerosis31 citations
Semantic Scholar
Radiologic MS disease activity during natalizumab treatment interruption: findings from RESTORE
M. Kaufman, B. Cree, J. de Sèze, R. Fox +10 more
2015Journal of Neurology26 citations
Semantic Scholar
Baseline MRI characteristics of patients at high risk for multiple sclerosis: results from the CHAMPS trial
J. Simon, P. O'Connor, P. Fleming, T. Gray +95 more
2002Multiple Sclerosis26 citations
Semantic Scholar
HLA DR and DQ alleles and haplotypes associated with clinical response to glatiramer acetate in multiple sclerosis.
S. Dhib-Jalbut, R. Valenzuela, Kouichi Ito, M. Kaufman +2 more
2013Multiple Sclerosis and Related Disorders25 citations
Semantic Scholar
Treatment of multiple sclerosis with high-dose corticosteroids may prolong the prothrombin time to dangerous levels in patients taking warfarin
M. Kaufman
1997Multiple Sclerosis23 citations
Semantic Scholar
Patient perceptions of multiple sclerosis-related care: Comparisons by practice specialty of principal care physician
R. Buchanan, M. Kaufman, Li Zhu, Wesley James
2008NeuroRehabilitation (Reading, MA)18 citations
Semantic Scholar
Health-Related Quality of Life Among Young Adults with Multiple Sclerosis
R. Buchanan, Chun-Feng Huang, M. Kaufman
201015 citations
Semantic Scholar
Predictive cytokine biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis.
R. Valenzuela, M. Kaufman, Konstantin E. Balashov, K. Ito +2 more
2016Journal of Neuroimmunology14 citations
Semantic Scholar
A randomized controlled pilot trial: the effects of EGb 761 on information processing and executive function in multiple sclerosis.
B. Diamond, Susan K. Johnson, M. Kaufman, S. Shiflett +1 more
2013Explore13 citations
Semantic Scholar
Predictors of short-term disease activity following a first clinical demyelinating event: analysis of the CHAMPS placebo groupy
P. O'Connor, P. Fleming, T. Gray, L. Jacobs +184 more
2002Multiple Sclerosis11 citations
Semantic Scholar
Examining the effects of stressors and resources on multiple sclerosis among African Americans and Whites
Susan K. Johnson, D. Terrell, C. Sargent, M. Kaufman
200710 citations
Semantic Scholar
RESTORE Study: Effects of a 24-Week Natalizumab Treatment Interruption on Immune Parameters and Multiple Sclerosis Magnetic Resonance Imaging Disease Activity (P06.168)
B. Cree, J. de Sèze, R. Fox, R. Gold +11 more
20129 citations
Semantic Scholar
Combining Therapies With Interferon Beta for Relapsing and Early Progressive MS: A Review
M. Kaufman
20029 citations
Semantic Scholar
Natalizumab Effects during a 6-Month Dose Interruption: Relationship of Pharmacokinetic (PK), Pharmacodynamic (PD), and MRI Measurements (S41.003)
B. Cree, J. de Sèze, R. Fox, R. Gold +9 more
2013Neurology8 citations
Semantic Scholar
Daclizumab HYP Versus Interferon Beta-1a in Relapsing-Remitting Multiple Sclerosis: Primary Results of the DECIDE Study (S4.003)
L. Kappos, K. Selmaj, D. Arnold, E. Havrdová +8 more
2015Neurology7 citations
Semantic Scholar
Do microbes with peptides mimicking myelin cause multiple sclerosis if the T cell response to their unique peptides is limited?
M. Kaufman
1998Journal of Theoretical Biology7 citations
Semantic Scholar
Safety and Tolerability Results From the DECIDE Study: A Phase 3 Active-Comparator Study of Daclizumab HYP in Relapsing-Remitting Multiple Sclerosis (P7.230)
K. Selmaj, L. Kappos, D. Arnold, E. Havrdová +8 more
2015Neurology5 citations
Semantic Scholar
Juvenile Metachromatic Leukodystrophy Mimicking Relapsing-Remitting Multiple Sclerosis
M. Kaufman
20064 citations Open access
Semantic Scholar
A Randomized Controlled Safety Trial of Interferon beta–1a and Oral Cyclophosphamide in MS
M. Kaufman, H. Norton, G. Sonnenfeld
20023 citations
Semantic Scholar
Ishihara's Tests for Color Blindness: A useful Indicator of Visual Involvement in Multiple Sclerosis
M. Kaufman, D. Lutz, J. Norton
20003 citations
Semantic Scholar
Daclizumab HYP Reduced Brain MRI Lesion Activity Compared With Interferon Beta-1a: Results from the DECIDE Study (P7.252)
J. Rose, H. Wiendl, D. Arnold, L. Kappos +8 more
2015Neurology2 citations
Semantic Scholar
Response to Mitoxantrone for Secondary Progressive Multiple Sclerosis in African Americans Compared with Whites
Linda A. Moore, M. Kaufman, J. Conway
20102 citations
Semantic Scholar
Neurologist Versus Nonneurologist Care of Multiple Sclerosis Patients
R. Buchanan, M. Kaufman, Li Zhu, Wesley James
20082 citations
Semantic Scholar
Effects of a 24-Week Natalizumab Treatment Interruption on Quality of Life, Fatigue, and Cognition: Results from the RESTORE Study (P06.171)
B. Weinstock-Guttman, B. Cree, J. de Sèze, RJ Fox +10 more
20121 citations
Semantic Scholar
Walking Capacity [WalkCap] Measured by Six-Minute Walk (6MW) Does Not Demonstrate Fatigue in Patients with Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS),and Parkinson Disease (PD) (P3.071)
M. Sanjak, L. Morgan, A.J. Simpson, S. Holsten +9 more
2014Neurology0 citations
Semantic Scholar
Motor Deficit Evaluated by Timed Functional Measures Correlate with Functional Rating Scale Used in Amyotrophic Lateral Sclerosis (ALS) and Multiple Sclerosis (MS), but Was in Discordance in Parkinson Disease (PD) (P04.193)
M. Sanjak, J. Mays, M. Hirsch, D. Englert +5 more
2013Neurology0 citations
Semantic Scholar
Natalizumab treatment interruption: RESTORE study baseline data
R. Gold, L. Kappos, R. Fox, B. Cree +8 more
20110 citations
Semantic Scholar
Longitudinal Assessment of Multiple Sclerosis Patients and Reimbursement Issues
M. Kaufman, G. Cutter, S. Schwid, K. Johnson +9 more
20050 citations Open access
Semantic Scholar
Multiple Sclerosis: Immunology, Pathology, and Pathophysiology
M. Kaufman
20030 citations
Semantic Scholar
Multiple Sclerosis: Diagnosis, Medical Management, and Rehabilitation
M. Kaufman
20000 citations
Semantic Scholar
Immune-based therapy of multiple sclerosis.
M. Kaufman
1995North Carolina Medical Journal0 citations
Semantic Scholar

P. Duda

×7

D. Jeffery×6

J. Elkins×5

M. Sweetser×5

J. de Sèze×5

Susan K. Johnson×5

B. Cree×5

R. Gold×5